Research Advisory Council

PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output

In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

Shabbir Alibhai, University Hospital Network, Toronto
Sam Aparicio, BC Cancer Agency, Vancouver
Steve Belway, Community Representative, Calgary
Robert Bristow (Scientific Chair), University Hospital Network, Toronto
Michael Brundage, Queens University, Kingston
Kerry Courneya, University of Alberta, Edmonton
Juanita Crook, BC Cancer Agency, Kelowna
Jim Davie, University of Manitoba, Winnipeg
Stuart Edmonds (Co-Chair), Prostate Cancer Canada,
Aaron Fenster, Robarts Research Institute, London
Martin Gleave, Vancouver Prostate Centre, Vancouver
William Nelson, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
John Oliffe, University of British Columbia, Vancouver
Rodney Ouellette, Atlantic Cancer Research Institute, Moncton
Marie-Elise Parent, INRS–Institut Armand-Frappier Research Centre, Laval
Robert Siemens, Queens University, Kingston
John Valliant, McMaster University, Hamilton

As of November 21, 2012
PCC Spotlight
A Race Against Time: New prostate cancer research gives 24,000 Canadian men a fighting chance

TORONTO, ONTARIO, September 30, 2014:  Prostate Cancer Canada is in a race to give the approximately 24,000 Canadian men diagnosed with prostate cancer each year a better fighting chance. More

Prostate Cancer Canada Supports Innovation with Awarding of Movember Discovery Grants

Toronto, ON – Aug 14, 2014 – As part of our ongoing strategic commitment to prostate cancer research, Prostate Cancer Canada (PCC) is proud to announce the recipients of the 2014 Movember Discovery Grants, awarded by PCC, funded by Movember. More


Click here for news archive